Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

evinacumab MeSH Supplementary Concept Data 2025


MeSH Supplementary
evinacumab
Unique ID
C000621590
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000621590
Entry Term(s)
REGN-1500
REGN1500
evinacumab-dgnb
evkeeza
Registry Numbers
T8B2ORP1DW
Heading Mapped to
*Antibodies, Monoclonal
Frequency
38
Note
an ANGPTL3-blocking antibody; FDA approved for the treatment of homozygous familial hypercholesterolemia.
Source
N Engl J Med. 2017 Jul 20;377(3):211-221.
Date of Entry
2017/07/30
Revision Date
2024/03/15
evinacumab Preferred
REGN-1500 Broader
evkeeza Narrower
evinacumab-dgnb Narrower
page delivered in 0.003s